• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4646951)   Today's Articles (2606)   Subscriber (50690)
For: Julius U, Fischer S, Schatz U, Hohenstein B, Bornstein SR. Lipoprotein apheresis: an update. ACTA ACUST UNITED AC 2013. [DOI: 10.2217/clp.13.68] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Number Cited by Other Article(s)
1
Sbrana F, Bigazzi F, Corciulo C, Dal Pino B. Lipoprotein apheresis reduces major adverse cardiovascular event incidence in high-lipoprotein (a) subjects on proprotein convertase subtilisin/kexin type 9 inhibitor therapy. Eur J Prev Cardiol 2024;31:e62-e64. [PMID: 38470832 DOI: 10.1093/eurjpc/zwae054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 12/07/2023] [Accepted: 02/07/2024] [Indexed: 03/14/2024]
2
Fang F, Zhao H, Wang R, Chen Q, Wang Q, Zhang Q. Facile Preparation of β-Cyclodextrin-Modified Polysulfone Membrane for Low-Density Lipoprotein Adsorption via Dopamine Self-Assembly and Schiff Base Reaction. MATERIALS (BASEL, SWITZERLAND) 2024;17:988. [PMID: 38473461 DOI: 10.3390/ma17050988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 02/18/2024] [Accepted: 02/19/2024] [Indexed: 03/14/2024]
3
Fang F, Zhao HY, Wang R, Chen Q, Wang QY, Zhang QH. Fabrication and Study of Dextran/Sulfonated Polysulfone Blend Membranes for Low-Density Lipoprotein Adsorption. MATERIALS (BASEL, SWITZERLAND) 2023;16:4641. [PMID: 37444954 DOI: 10.3390/ma16134641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 06/17/2023] [Accepted: 06/24/2023] [Indexed: 07/15/2023]
4
Sampietro T, Pino BD, Bigazzi F, Sbrana F, Ripoli A, Fontanelli E, Pianelli M, Luciani R, Lepri A, Calzetti G. Acute Increase in Ocular Microcirculation Blood Flow Upon Cholesterol Removal. The Eyes Are the Window of the Heart. Am J Med 2023;136:108-114. [PMID: 36152804 DOI: 10.1016/j.amjmed.2022.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Revised: 03/08/2022] [Accepted: 08/06/2022] [Indexed: 12/13/2022]
5
Kuss SFR, Schatz U, Tselmin S, Fischer S, Julius U. The development of lipoprotein apheresis in Saxony in the last years. Ther Apher Dial 2022;26 Suppl 1:53-63. [PMID: 36584880 DOI: 10.1111/1744-9987.13940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 09/23/2022] [Accepted: 10/11/2022] [Indexed: 01/01/2023]
6
Sampietro T, Sbrana F, Dal Pino B, Bigazzi F, Ripoli A, Marzullo P, Gimelli A. Coronary microcirculatory blood flow significantly increases upon acute and chronic cholesterol lowering. evaluation by cadmium-zinc-telluride cardiac imaging stress test. Eur J Prev Cardiol 2022;29:e272-e274. [PMID: 35234871 DOI: 10.1093/eurjpc/zwac043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 02/04/2022] [Accepted: 02/28/2022] [Indexed: 11/15/2022]
7
Sbrana F, Dal Pino B, Bigazzi F, Ripoli A, Passino C, Gabutti A, Pasanisi EM, Petersen C, Valleggi A, Todiere G, Barison A, Giannoni A, Panchetti L, Becherini F, Pianelli M, Luciani R, Sampietro T. Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? Eur J Prev Cardiol 2020;24:1528-1531. [DOI: 10.1177/2047487317712419] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
8
Greco MF, Sirtori CR, Corsini A, Ezhov M, Sampietro T, Ruscica M. Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach. J Clin Med 2020;9:jcm9072103. [PMID: 32635396 PMCID: PMC7408876 DOI: 10.3390/jcm9072103] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2020] [Revised: 06/24/2020] [Accepted: 07/01/2020] [Indexed: 12/11/2022]  Open
9
Tselmin S, Julius U, Weinert N, Bornstein SR, Schatz U. Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis. ATHEROSCLEROSIS SUPP 2019;40:38-43. [DOI: 10.1016/j.atherosclerosissup.2019.08.045] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
10
Fang F, Huang XJ, Guo YZ, Hong X, Wu HM, Liu R, Chen DJ. Selective and Regenerable Surface Based on β-Cyclodextrin for Low-Density Lipoprotein Adsorption. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2018;34:8163-8169. [PMID: 29921121 DOI: 10.1021/acs.langmuir.8b00883] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
11
Jellinghaus S, Reich C, Schatz U, Tselmin S, Ibrahim K, Pfluecke C, Schauer A, Bornstein SR, Hohenstein B, Strasser RH, Julius U, Poitz DM. Lipoprotein apheresis influences monocyte subpopulations. ATHEROSCLEROSIS SUPP 2017;30:108-114. [PMID: 29096825 DOI: 10.1016/j.atherosclerosissup.2017.05.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
12
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study. ATHEROSCLEROSIS SUPP 2017;30:246-252. [DOI: 10.1016/j.atherosclerosissup.2017.05.047] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
13
Sampietro T, Sbrana F, Pasanisi EM, Bigazzi F, Petersen C, Coceani M, Dal Pino B, Ripoli A, Pianelli M, Luciani R. LDL apheresis improves coronary flow reserve on the left anterior descending artery in patients with familial hypercholesterolemia and chronic ischemic heart disease. ATHEROSCLEROSIS SUPP 2017;30:135-140. [DOI: 10.1016/j.atherosclerosissup.2017.05.038] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
14
Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs. J Clin Lipidol 2017;11:858-871.e3. [DOI: 10.1016/j.jacl.2017.04.114] [Citation(s) in RCA: 92] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Revised: 03/30/2017] [Accepted: 04/15/2017] [Indexed: 12/11/2022]
15
Kopprasch S, Bornstein SR, Bergmann S, Graessler J, Hohenstein B, Julius U. Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI). ATHEROSCLEROSIS SUPP 2017;30:115-121. [PMID: 29096826 DOI: 10.1016/j.atherosclerosissup.2017.05.029] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
16
Fang F, Zhu XY, Chen C, Li J, Chen DJ, Huang XJ. Anionic glycosylated polysulfone membranes for the affinity adsorption of low-density lipoprotein via click reactions. Acta Biomater 2017;49:379-387. [PMID: 27884777 DOI: 10.1016/j.actbio.2016.11.050] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 11/11/2016] [Accepted: 11/20/2016] [Indexed: 01/22/2023]
17
France M, Rees A, Datta D, Thompson G, Capps N, Ferns G, Ramaswami U, Seed M, Neely D, Cramb R, Shoulders C, Barbir M, Pottle A, Eatough R, Martin S, Bayly G, Simpson B, Halcox J, Edwards R, Main L, Payne J, Soran H. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis 2016;255:128-139. [DOI: 10.1016/j.atherosclerosis.2016.10.017] [Citation(s) in RCA: 61] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 08/03/2016] [Accepted: 10/07/2016] [Indexed: 12/16/2022]
18
Kopprasch S, Bornstein SR, Bergmann S, Graessler J, Julius U. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques. ATHEROSCLEROSIS SUPP 2016;18:80-4. [PMID: 25936309 DOI: 10.1016/j.atherosclerosissup.2015.02.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
19
Julius U, Siegert G, Kostka H, Schatz U, Hohenstein B. Effects of different lipoprotein apheresis methods on serum protein levels. ATHEROSCLEROSIS SUPP 2016;18:95-102. [PMID: 25936311 DOI: 10.1016/j.atherosclerosissup.2015.02.018] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
20
Julius U, Milton M, Stoellner D, Rader D, Gordon B, Polk D, Waldmann E, Parhofer K, Moriarty P. Effects of lipoprotein apheresis on PCSK9 levels. ATHEROSCLEROSIS SUPP 2015;18:180-6. [DOI: 10.1016/j.atherosclerosissup.2015.02.028] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
21
Actual situation of lipoprotein apheresis in Saxony in 2013. ATHEROSCLEROSIS SUPP 2015;18:215-25. [DOI: 10.1016/j.atherosclerosissup.2015.02.034] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
22
Schatz U, Illigens B, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein S, Julius U. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. ATHEROSCLEROSIS SUPP 2015;18:199-208. [DOI: 10.1016/j.atherosclerosissup.2015.02.030] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
23
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment. ATHEROSCLEROSIS SUPP 2015;18:209-14. [DOI: 10.1016/j.atherosclerosissup.2015.02.031] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
24
Dittrich-Riediger J, Schatz U, Hohenstein B, Julius U. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden. ATHEROSCLEROSIS SUPP 2015;18:45-52. [DOI: 10.1016/j.atherosclerosissup.2015.02.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
25
Kassner U, Schlabs T, Rosada A, Steinhagen-Thiessen E. Lipoprotein(a) – An independent causal risk factor for cardiovascular disease and current therapeutic options. ATHEROSCLEROSIS SUPP 2015;18:263-7. [DOI: 10.1016/j.atherosclerosissup.2015.02.039] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
26
The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience. ATHEROSCLEROSIS SUPP 2015;18:268-72. [DOI: 10.1016/j.atherosclerosissup.2015.02.040] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
27
Liu Y, Qiu WZ, Yang HC, Qian YC, Huang XJ, Xu ZK. Polydopamine-assisted deposition of heparin for selective adsorption of low-density lipoprotein. RSC Adv 2015. [DOI: 10.1039/c4ra16700g] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA